1 Table of contents
I Table of contents 3
I. 1 List of Data tables 6
I. 2 List of Charts 7
II Introduction 9
II. 1 GlobalData Report Guidance 9
3 Disease Data : Renal Failure 10
III. 1 Introduction 10
III. 2 Pathophysiology 10
III. 3 Types of Renal Failure 11
III. 3.1 Acute Renal Failure (ARF) or Acute Kidney Injury (AKI) 12
III. 3.2 Chronic Renal Failure (CRF) or Chronic Kidney Disease (CKD) 14
III. 3.3 Distinction between Acute Renal Failure and Chronic Renal Failure 16
III. 4 Etiology and Risk Factors 16
III. 5 Signs and Symptoms 19
III. 6 Comorbid Conditions 20
III. 6.1 Diabetes: Diabetic Nephropathy 20
III. 6.2 Hypertension 20
III. 6.3 Anemia 20
III. 7 Epidemiology, Patient Population and Death Rate 21
III. 7.1 ARF 21
III. 7.2 CRF 21
III. 7.3 ESRD 21
III. 8 Diagnosis for Measuring Kidney Function 23
III. 8.1 Physical Examination 23
III. 8.2 Diagnostic Tests 24
III. 9 Treatment Options 26
IV Device-Based Treatment Modalities 27
IV. 1 Dialysis 27
IV. 1.1 Dialysis Machine 27
IV. 1.2 Types of Dialysis 27
IV. 1.3 Home Hemodialysis and In-Center Hemodialysis 30
IV. 2 Dialysis Modalities in Intensive Care Unit 34
IV. 2.1 Continuous Venovenous Hemofiltration (CVVH) 34
IV. 2.2 Continuous Venovenous Hemodiafiltration (CVVHDF) 34
IV. 2.3 Continuous Venovenous Hemodialysis (CVVHD) 34
IV. 2.4 Slow, Continuous Ultrafiltration 34
IV. 2.5 Benefits of Continuous Renal Replacement Therapy 35
IV. 2.6 Initiating Dialysis 35
IV. 2.7 Modality selection 35
IV. 2.8 Aftercare 36
IV. 2.9 Complications Associated with Dialysis 37
V Treatment Cost of Dialysis and Reimbursement 38
V. 1 Treatment Cost of Dialysis 38
V. 2 Cost Comparison of Dialysis Treatment Modalities 38
V. 3 Reimbursement for Dialysis Treatment 38
V. 3.1 Medicare 38
V. 3.2 Medicaid 40
V. 3.3 Private and Group Insurance 40
V. 3.4 Social Service Agencies 40
V. 4 US Healthcare Reform on Renal Dialysis Equipment March ket: Bundle Payment 40
V. 4.1 Impact of the Bundled Payment System 41
VI Renal Dialysis Equipment: March ket Characterization 42
VI. 1 Renal Dialysis Equipment March ket, Global, Sales ($bn), Historical data, from 2003 to 2010 42
VI. 2 Renal Dialysis Equipment March ket, Global, Sales ($bn), Forecasted data, from 2010 to 2017 43
VI. 3 Renal Dialysis Equipment March ket, Global, Key Trends 44
VI. 3.1 Peritoneal Dialysis to Gain Preference over Hemodialysis 44
VI. 3.2 Increase in Use of Alternate Hemodialysis Regimens 44
VI. 3.3 Integration of Product Manufacturers and Service Providers is a Rising Trend 45
VI. 3.4 Wearable Artificial Kidney – A November el Technology Trend 46
VI. 4 Renal Dialysis Equipment March ket, Global, March ket Dynamics 46
VI. 4.1 March ket Drivers 47
VI. 4.2 March ket Restraints 54
VI. 4.3 Unmet Need and Opportunity Analysis 56
VII Renal Dialysis Equipment March ket: Segment Analysis 58
VII. 1 World Hemodialysis Machines March ket 58
VII. 1.1 Hemodialysis Machines March ket, Global, Sales (USD Million), Historical data, from 2003 to 2010 59
VII. 1.2 Hemodialysis Machines March ket, Global, Sales (USD Million), Forecasted data, from 2010 to 2017 60
VII. 1.3 Hemodialysis Machines, March ket Driver: Private Dialysis Service Providers Preference for Hemodialysis and Availability of Reimbursement to Drive March ket Growth 61
VII. 1.4 Hemodialysis Machines, March ket Restraint: Medical Complications Associated with Hemodialysis and Contradiction in Various Studies Over Improved Mortality Rate in Hemodialysis Over Peritoneal Dialysis to Slow Adoption 61
VII. 2 World Peritoneal Dialysis Solutions March ket 62
VII. 2.1 Peritoneal Dialysis Solutions March ket, Global, Sales ($bn), Historical data, from 2003 to 2010 62
VII. 2.2 Peritoneal Dialysis Solutions March ket, Global, Sales ($bn), Forecasted data, from 2010 to 2017 63
VII. 2.3 Peritoneal Dialysis Solutions, March ket Driver: Increasing Healthcare Spending Burden is Encouraging Peritoneal Dialysis as a Treatment Option for Renal Diseases 63
VII. 2.4 Peritoneal Dialysis Solutions, March ket Restraint: Medical Complications Associated with Peritoneal Dialysis 64
VII. 3 World Continuous Renal Replacement Therapy (CRRT) Machines March ket 65
VII. 3.1 Continuous Renal Replacement Therapy Machines March ket, Global, Sales (USD Million), Historical data, from 2003 to 2010 65
VII. 3.2 Continuous Renal Replacement Therapy Machines March ket, Global, Sales (USD Million), Forecasted data, from 2010 to 2017 66
VII. 3.3 Continuous Renal Replacement Therapy Machines, March ket Driver: Advantages of CRRT Over Other Dialysis Modalities to Increase Adoption of CRRT 67
VII. 3.4 Continuous Renal Replacement Therapy Machines, March ket Restraint: A Multidisciplinary Team is Required to Perform Continuous Renal Replacement Therapy 67
VII. 4 World Dialysis Accessories March ket 67
VII. 4.1 Overview 67
VII. 4.2 Dialysis Accessories March ket, Global, Sales (USD Million), Historical data, from 2003 to 2010 68
VII. 4.3 Dialysis Accessories, Global, Sales (USD Million), Forecasted data, from 2010 to 2017 69
VII. 4.4 Dialysis Accessories, March ket Driver: Increasing Uptake of Single Use Dialyzers to Drive the March ket 70
VII. 4.5 Dialysis Accessories, March ket Restraint: Complications Associated with Catheters and Dialyzers may Slow their Adoption 70
8 World Renal Dialysis Equipment March ket, by Country, Sales (USD Million), from 2003 to 2017 71
VIII. 1 Renal Dialysis Equipment March ket, US, Sales (USD Million), Historical data, from 2003 to 2010 71
VIII. 2 Renal Dialysis Equipment March ket, The US, Sales (USD Million), Forecasted data, from 2010 to 2017 72
VIII. 3 Renal Dialysis Equipment March ket, Canada, Sales (USD Million), Historical data, from 2003 to 2010 73
VIII. 4 Renal Dialysis Equipment March ket, Canada, Sales (USD Million), Forecasted data, from 2010 to 2017 74
VIII. 5 Renal Dialysis Equipment March ket, The UK, Sales (USD Million), Historical data, from 2003 to 2010 75
VIII. 6 Renal Dialysis Equipment March ket, The UK, Sales (USD Million), Forecasted data, from 2010 to 2017 76
VIII. 7 Renal Dialysis Equipment March ket, Germany, Sales (USD Million), Historical data, from 2003 to 2010 77
VIII. 8 Renal Dialysis Equipment March ket, Germany, Sales (USD Million), Forecasted data, from 2010 to 2017 78
VIII. 9 Renal Dialysis Equipment March ket, France, Sales (USD Million), Historical data, from 2003 to 2010 79
VIII. 10 Renal Dialysis Equipment March ket, France, Sales (USD Million), Forecasted data, from 2010 to 2017 80
VIII. 11 Renal Dialysis Equipment March ket, Italy, Sales (USD Million), Historical data, from 2003 to 2010 81
VIII. 12 Renal Dialysis Equipment March ket, Italy, Sales (USD Million), Forecasted data, from 2010 to 2017 82
VIII. 13 Renal Dialysis Equipment March ket, Spain, Sales (USD Million), Historical data, from 2003 to 2010 83
VIII. 14 Renal Dialysis Equipment March ket, Spain, Sales (USD Million), Forecasted data, from 2010 to 2017 84
VIII. 15 Renal Dialysis Equipment March ket, Japan, Sales (USD Million), Historical data, from 2003 to 2010 85
VIII. 16 Renal Dialysis Equipment March ket, Japan, Sales (USD Million), Forecasted data, from 2010 to 2017 86
VIII. 17 Renal Dialysis Equipment March ket, China, Sales (USD Million), Historical data, from 2003 to 2010 87
VIII. 18 Renal Dialysis Equipment March ket, China, Sales (USD Million), Forecasted data, from 2010 to 2017 88
VIII. 19 Renal Dialysis Equipment March ket, India, Sales (USD Million), Historical data, from 2003 to 2010 89
VIII. 20 Renal Dialysis Equipment March ket, India, Sales (USD Million), Forecasted data, from 2010 to 2017 90
VIII. 21 Renal Dialysis Equipment March ket, Australia, Sales (USD Million), Historical data, from 2003 to 2010 91
VIII. 22 Renal Dialysis Equipment March ket, Australia, Sales (USD Million), Forecasted data, from 2010 to 2017 92
VIII. 23 Renal Dialysis Equipment March ket, Brazil, Sales (USD Million), Historical data, from 2003 to 2010 93
VIII. 24 Renal Dialysis Equipment March ket, Brazil, Sales (USD Million), Forecasted data, from 2010 to 2017 94
9 World Renal Dialysis Equipment March ket: Competitive Assessment 95
IX. 1 Renal Dialysis Equipment March ket, Global, Market Shares (%), 2010 95
IX. 2 Renal Dialysis Equipment March ket, Opportunities (SWOT Analysis) and Threats (SWOT Analysis) 96
IX. 3 Renal Dialysis Equipment March ket, Key March ket Participants 97
IX. 3.1 Fresenius Medical Care AG & Co. KGaA 97
IX. 3.2 Baxter International Inc. 99
IX. 3.3 Gambro AB 101
IX. 3.4 NIPRO CORPORATION 103
IX. 3.5 B.Braun Melsungen AG 105
X Global Renal Dialysis Equipment March ket: Strategic Pipeline Assessment 107
X. 1 Pipeline Assessment by Development Stage 107
X. 2 Renal Dialysis Equipment, Pipeline Products Summary 108
X. 3 Profiles of Key Products Under Clinical Development 110
X. 3.1 Theralite 110
X. 3.2 APD Cycler - Next Generation 110
X. 3.3 Home Hemodialysis System 111
X. 3.4 AK 200 ULTRA S 112
X. 3.5 Artis System 112
X. 3.6 OLpur MD 220 113
X. 3.7 Wearable Artificial Kidney 114
XI Global Renal Dialysis Equipment March ket: Startegic Deal Analysis 116
XI. 1 Key Deals - Mergers and Acquisitions 116
XI. 1.1 Fresenius Medical Care Takes Over Hema Metrics Crit-Line system business 116
XI. 1.2 Fresenius Medical Care Takes Over Peritoneal Dialysis Business from Gambro 116
XI. 1.3 Fresenius Medical Takes Over Renal Solutions 116
XI. 1.4 NxStage Medical Takes Over Medisystems 117
XI. 1.5 Gambro Takes Over Hemapure 117
XI. 2 Key Deals – Partner agreements 117
XI. 2.1 Fresenius Medical Care Enters Into an Agreement with NIKKISO 117
XI. 2.2 NxStage Signs Distribution Agreement with Spindial for System One 117
XI. 2.3 Interface Biologics Signs Exclusive License Option Agreement with Fresenius Medical Care 118
XI. 2.4 Gambro Enters Into an Agreement with Debiotech 118
XI. 3 Key Deals – Private Equity / Venture Capital 118
XI. 3.1 EQT and Investor AB Takes Over Gambro through Indap 118
XII Appendix 119
XII. 1 Definitions 119
XII. 1.1 Renal Dialysis Equipment 119
XII. 1.2 Hemodialysis Machines 119
XII. 1.3 Peritoneal Dialysis Solutions 120
XII. 1.4 Continuous Renal Replacement Therapy Machines 120
XII. 1.5 Dialysis Accessories 120
XII. 2 Acronyms 120
XII. 3 Research Methodology 121
XII. 4 Secondary Research 121
XII. 5 Primary Research 122
XII. 6 Models 122
XII. 7 Forecasted data s 122
XII. 8 Expert Panels 122
XII. 9 GlobalData Consulting 123
XII. 10 Contact Us 123
XII. 11 Disclaimer 123
XII. 12 Sources 123
1.1 List of Data tables
Data table 1: ESRD Prevalence Rates (pmp), World by Year, 1999-2009 21
Data table 2: Prevalence of ESRD, by Country, 2008 22
Data table 3: Types of Diagnostic Tests for Measuring Kidney Function 24
Data table 4: Tests for Measure of Diabetes Control in Kidney Disease Patients 25
Data table 5: Tests for Measure of Anemia in Kidney Disease Patients 25
Data table 6: Dialysis Prevalence Rates (pmp), World by Year, 1999-2009 26
Data table 7: Test for the Measure of Nutrition in Kidney Disease Patients 36
Data table 8: Daily Dietary Recommendations for Dialysis Patients 37
Data table 9: Total Medicare Expenditure ($bn) on ESRD, by Modality, The US, from 2000 to 2008 40
Data table 10: Renal Dialysis Equipment March ket, Global, Sales ($bn), from 2003 to 2010 42
Data table 11: Renal Dialysis Equipment March ket, Global, Sales ($bn), from 2010 to 2017 43
Data table 12: Percentage of Incident Patients with ESRD Caused by Diabetes, by Year, 2008 48
Data table 13: Diabetes Prevalence in Adults Aged 20-79, By Country, 2010-2030 49
Data table 14: Elderly Population, by Country, 2009-2050 51
Data table 15: Hemodialysis Machines March ket, Global, Sales (USD Million), from 2003 to 2010 59
Data table 16: Hemodialysis Machines March ket, Global, Sales (USD Million), from 2010 to 2017 60
Data table 17: Possible Complications of Hemodialysis 61
Data table 18: Peritoneal Dialysis Solutions March ket, Global, Sales ($bn), from 2003 to 2010 62
Data table 19: Peritoneal Dialysis Solutions March ket, Global, Sales ($bn), from 2010 to 2017 63
Data table 20: Possible Complications of Peritoneal Dialysis 64
Data table 21: Continuous Renal Replacement Therapy Machines March ket, Global, Sales (USD Million), from 2003 to 2010 65
Data table 22: Continuous Renal Replacement Therapy Machines March ket, Global, Sales (USD Million), from 2010 to 2017 66
Data table 23: Dialysis Accessories March ket, Global, Sales (USD Million), from 2003 to 2010 68
Data table 24: Dialysis Accessories March ket, Global, Sales (USD Million), from 2010 to 2017 69
Data table 25: Renal Dialysis Equipment March ket, The US, Sales (USD Million), from 2003 to 2010 71
Data table 26: Renal Dialysis Equipment March ket, The US, Sales (USD Million), from 2010 to 2017 72
Data table 27: Renal Dialysis Equipment March ket, Canada, Sales (USD Million), from 2003 to 2010 73
Data table 28: Renal Dialysis Equipment March ket, Canada, Sales (USD Million), from 2010 to 2017 74
Data table 29: Renal Dialysis Equipment March ket, The UK, Sales (USD Million), from 2003 to 2010 75
Data table 30: Renal Dialysis Equipment March ket, The UK, Sales (USD Million), from 2010 to 2017 76
Data table 31: Renal Dialysis Equipment March ket, Germany, Sales (USD Million), from 2003 to 2010 77
Data table 32: Renal Dialysis Equipment March ket, Germany, Sales (USD Million), from 2010 to 2017 78
Data table 33: Renal Dialysis Equipment March ket, France, Sales (USD Million), from 2003 to 2010 79
Data table 34: Renal Dialysis Equipment March ket, France, Sales (USD Million), from 2010 to 2017 80
Data table 35: Renal Dialysis Equipment March ket, Italy, Sales (USD Million), from 2003 to 2010 81
Data table 36: Renal Dialysis Equipment March ket, Italy, Sales (USD Million), from 2010 to 2017 82
Data table 37: Renal Dialysis Equipment March ket, Spain, Sales (USD Million), from 2003 to 2010 83
Data table 38: Renal Dialysis Equipment March ket, Spain, Sales (USD Million), from 2010 to 2017 84
Data table 39: Renal Dialysis Equipment March ket, Japan, Sales (USD Million), Historical data, from 2003 to 2010 85
Data table 40: Renal Dialysis Equipment March ket, Japan, Sales (USD Million), from 2010 to 2017 86
Data table 41: Renal Dialysis Equipment March ket, China, Sales (USD Million), from 2003 to 2010 87
Data table 42: Renal Dialysis Equipment March ket, China, Sales (USD Million), from 2010 to 2017 88
Data table 43: Renal Dialysis Equipment March ket, India, Sales (USD Million), from 2003 to 2010 89
Data table 44: Renal Dialysis Equipment March ket, India, Sales (USD Million), from 2010 to 2017 90
Data table 45: Renal Dialysis Equipment March ket, Australia, Sales (USD Million), from 2003 to 2010 91
Data table 46: Renal Dialysis Equipment March ket, Australia, Sales (USD Million), from 2010 to 2017 92
Data table 47: Renal Dialysis Equipment March ket, Brazil, Sales (USD Million), from 2003 to 2010 93
Data table 48: Renal Dialysis Equipment March ket, Brazil, Sales (USD Million), from 2010 to 2017 94
Data table 49: Renal Dialysis Equipment March ket, Global, Firms Sales (USD Million), 2010 95
Data table 50: Fresenius Medical Care AG & Co. KGaA, Key March keted Products, 2011 97
Data table 51: Baxter International Inc., Key March keted Products, 2011 100
Data table 52: Gambro AB, Key March keted Products, 2011 102
Data table 53: NIPRO CORPORATION, Key March keted Products, 2011 104
Data table 54: B.Braun Melsungen AG, Key March keted Products, 2011 105
Data table 55: World Renal Dialysis Equipment, Pipeline Products Summary, 2010 108
Data table 56: Theralite, Product Status, 2011 110
Data table 57: APD Cycler - Next Generation, Product Status, 2011 110
Data table 58: Home Hemodialysis System, Product Status, 2011 111
Data table 59: Home Hemodialysis System 111
Data table 60: AK 200 ULTRA S, Product Status, 2011 112
Data table 61: Artis System, Product Status, 2011 112
Data table 62: OLpur MD 220, Product Status, 2011 113
Data table 63: OLpur MD 220, Clinical Trial, 2011 113
Data table 64: Wearable Artificial Kidney, Product Status, 2011 114
Data table 65: Wearable Artificial Kidney, Clinical Trial, 2011 114
1.2 List of Charts
Chart 1: Functions of the Kidney and Pathophysiology of Renal Failure 10
Chart 2: Types of Renal Failure 11
Chart 3: Causes of Acute Renal Failure 12
Chart 4: Stages of Chronic Renal Failure 14
Chart 5: Distinguishing Acute Renal Failure from Chronic Renal Failure on the Basis of a Difference in Test Result Findings 16
Chart 6: Causes of Renal Failure, US, 2007 17
Chart 7: Causes of Renal Failure, Europe, 2007 18
Chart 8: Causes of Renal Failure, Australia, 2009 18
Chart 9: Risk Factors for Chronic Renal Failure 19
Chart 10: Prevalence of ESRD, by Country, 2008 22
Chart 11: Advantages and Disadvantages of Continuous Ambulatory Peritoneal Dialysis Relative to Hemodialysis 28
Chart 12: Comparison of Hemodialysis and Peritoneal Dialysis 29
Chart 13: Comparison of Home Hemodialysis and In-Center Hemodialysis 31
Chart 14: Comparison of Benefits of Peritoneal Dialysis, Home Hemodialysis and In-Center Hemodialysis 32
Chart 15: Comparison of Drawbacks of Peritoneal Dialysis, Home Hemodialysis and In-Center Hemodialysis 33
Chart 16: Types of Continuous Renal Replacement Therapy 34
Chart 17: Short-Term and Long-Term Benefits of Continuous Renal Replacement Therapy 35
Chart 18: Dialysis Associated Cost Covered by Medicare, The US, 2011 39
Chart 19: Renal Dialysis Equipment March ket, Global, Sales ($bn), from 2003 to 2010 42
Chart 20: Renal Dialysis Equipment March ket, Global, Sales ($bn), from 2010 to 2017 43
Chart 21: Vertical Integration – A Rising Trend in Renal Dialysis Equipment March ket 45
Chart 22: Renal Dialysis Equipment March ket, Global, March ket Dynamics 46
Chart 23: Percentage of Incident Patients with ESRD Caused by Diabetes, by Year, 2008 47
Chart 24: Diabetes Prevalence in Adults Aged 20-79, By Country, 2010-2030 49
Chart 25: Elderly Population, by Country, 2009-2050 50
Chart 26: Number of Dialysis Patients by Year, Brazil, 2009 54
Chart 27: Areas of Improvement in Dialysis Care 56
Chart 28: Renal Dialysis Equipment March ket, Segmentation, 2010 58
Chart 29: Hemodialysis Machines March ket, Global, Sales (USD Million), from 2003 to 2010 59
Chart 30: Hemodialysis Machines March ket, Global, Sales (USD Million), from 2010 to 2017 60
Chart 31: Peritoneal Dialysis Solutions March ket, Global, Sales ($bn), from 2003 to 2010 62
Chart 32: Peritoneal Dialysis Solutions March ket, Global, Sales ($bn), from 2010 to 2017 63
Chart 33: Continuous Renal Replacement Therapy Machines March ket, Global, Sales (USD Million), from 2003 to 2010 65
Chart 34: Continuous Renal Replacement Therapy Machines March ket, Global, Sales (USD Million), from 2010 to 2017 66
Chart 35: Dialysis Accessories March ket, Global, Sales (USD Million), from 2003 to 2010 68
Chart 36: Dialysis Accessories March ket, Global, Sales (USD Million), from 2010 to 2017 69
Chart 37: Renal Dialysis Equipment March ket, The US, Sales (USD Million), from 2003 to 2010 71
Chart 38: Renal Dialysis Equipment March ket, The US, Sales (USD Million), from 2010 to 2017 72
Chart 39: Renal Dialysis Equipment March ket, Canada, Sales (USD Million), from 2003 to 2010 73
Chart 40: Renal Dialysis Equipment March ket, Canada, Sales (USD Million), from 2010 to 2017 74
Chart 41: Renal Dialysis Equipment March ket, The UK, Sales (USD Million), from 2003 to 2010 75
Chart 42: Renal Dialysis Equipment March ket, The UK, Sales (USD Million), from 2010 to 2017 76
Chart 43: Renal Dialysis Equipment March ket, Germany, Sales (USD Million), from 2003 to 2010 77
Chart 44: Renal Dialysis Equipment March ket, Germany, Sales (USD Million), from 2010 to 2017 78
Chart 45: Renal Dialysis Equipment March ket, France, Sales (USD Million), from 2003 to 2010 79
Chart 46: Renal Dialysis Equipment March ket, France, Sales (USD Million), from 2010 to 2017 80
Chart 47: Renal Dialysis Equipment March ket, Italy, Sales (USD Million), from 2003 to 2010 81
Chart 48: Renal Dialysis Equipment March ket, Italy, Sales (USD Million), from 2010 to 2017 82
Chart 49: Renal Dialysis Equipment March ket, Spain, Sales (USD Million), from 2003 to 2010 83
Chart 50: Renal Dialysis Equipment March ket, Spain, Sales (USD Million), from 2010 to 2017 84
Chart 51: Renal Dialysis Equipment March ket, Japan, Sales (USD Million), Historical data, from 2003 to 2010 85
Chart 52: Renal Dialysis Equipment March ket, Japan, Sales (USD Million), from 2010 to 2017 86
Chart 53: Renal Dialysis Equipment March ket, China, Sales (USD Million), from 2003 to 2010 87
Chart 54: Renal Dialysis Equipment March ket, China, Sales (USD Million), from 2010 to 2017 88
Chart 55: Renal Dialysis Equipment March ket, India, Sales (USD Million), from 2003 to 2010 89
Chart 56: Renal Dialysis Equipment March ket, India, Sales (USD Million), from 2010 to 2017 90
Chart 57: Renal Dialysis Equipment March ket, Australia, Sales (USD Million), from 2003 to 2010 91
Chart 58: Renal Dialysis Equipment March ket, Australia, Sales (USD Million), from 2010 to 2017 92
Chart 59: Renal Dialysis Equipment March ket, Brazil, Sales (USD Million), from 2003 to 2010 93
Chart 60: Renal Dialysis Equipment March ket, Brazil, Sales (USD Million), from 2010 to 2017 94
Chart 61: Renal Dialysis Equipment March ket, Global, Market Shares (%), 2010 95
Chart 62: Renal Dialysis Equipment March ket, Global, Opportunities (SWOT Analysis) and Threats (SWOT Analysis) 96
Chart 63: Fresenius Medical Care AG & Co. KGaA, Internal Factors Evaluation 98
Chart 64: Baxter International Inc., Internal Factors Evaluation 100
Chart 65: Gambro AB, Internal Factors Evaluation 102
Chart 66: NIPRO CORPORATION, Internal Factors Evaluation 104
Chart 67: B.Braun Melsungen AG, Internal Factors Evaluation 105
Chart 68: Renal Dialysis Equipment March ket, Global, Pipeline Products by Stage 107
Companies Mentioned